Cargando…
The Evolving Role of Marked Lymph Node Biopsy (MLNB) and Targeted Axillary Dissection (TAD) after Neoadjuvant Chemotherapy (NACT) for Node-Positive Breast Cancer: Systematic Review and Pooled Analysis
SIMPLE SUMMARY: The 5-year survival rate for patients with breast cancer, in whom disease has spread to local lymph nodes, is 85%. However, many live with the complications of surgery to remove the lymph nodes in the armpit thus impacting their quality of life. In recent years, new approaches have b...
Autores principales: | Swarnkar, Parinita K., Tayeh, Salim, Michell, Michael J., Mokbel, Kefah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8037051/ https://www.ncbi.nlm.nih.gov/pubmed/33810544 http://dx.doi.org/10.3390/cancers13071539 |
Ejemplares similares
-
“This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients”
por: Galimberti, Viviana, et al.
Publicado: (2022) -
Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study
por: Mokbel, Kefah, et al.
Publicado: (2023) -
The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review
por: Tayeh, Salim, et al.
Publicado: (2021) -
Omitting Sentinel Lymph Node Biopsy after Neoadjuvant Systemic Therapy for Clinically Node Negative HER2 Positive and Triple Negative Breast Cancer: A Pooled Analysis
por: Alamoodi, Munaser, et al.
Publicado: (2023) -
The competent sentinel node: an association with an axillary presentation and an occult or a small primary invasive breast carcinoma
por: Mansfield, Lucy, et al.
Publicado: (2006)